These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30630527)

  • 1. Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer.
    Maletzki C; Wiegele L; Nassar I; Stenzel J; Junghanss C
    J Immunother Cancer; 2019 Jan; 7(1):8. PubMed ID: 30630527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors.
    Salewski I; Kuntoff S; Kuemmel A; Feldtmann R; Felix SB; Henze L; Junghanss C; Maletzki C
    Cancer Immunol Immunother; 2021 Dec; 70(12):3405-3419. PubMed ID: 33870463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors.
    Salewski I; Henne J; Engster L; Schneider B; Lemcke H; Skorska A; Berlin P; Henze L; Junghanss C; Maletzki C
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular vaccination of MLH1
    Maletzki C; Gladbach YS; Hamed M; Fuellen G; Semmler ML; Stenzel J; Linnebacher M
    Oncoimmunology; 2018; 7(3):e1408748. PubMed ID: 29399413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters.
    Salewski I; Gladbach YS; Kuntoff S; Irmscher N; Hahn O; Junghanss C; Maletzki C
    J Transl Med; 2020 Oct; 18(1):402. PubMed ID: 33087163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma.
    Ghansah T; Vohra N; Kinney K; Weber A; Kodumudi K; Springett G; Sarnaik AA; Pilon-Thomas S
    Cancer Immunol Immunother; 2013 Jun; 62(6):1083-91. PubMed ID: 23604104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.
    Suzuki E; Kapoor V; Jassar AS; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Sep; 11(18):6713-21. PubMed ID: 16166452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
    Tongu M; Harashima N; Monma H; Inao T; Yamada T; Kawauchi H; Harada M
    Cancer Immunol Immunother; 2013 Feb; 62(2):383-91. PubMed ID: 22926062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.
    Le HK; Graham L; Cha E; Morales JK; Manjili MH; Bear HD
    Int Immunopharmacol; 2009 Jul; 9(7-8):900-9. PubMed ID: 19336265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy.
    Zhang X; Liang Q; Cao Y; Yang T; An M; Liu Z; Yang J; Liu Y
    J Nanobiotechnology; 2024 Jun; 22(1):319. PubMed ID: 38849938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic DNA vaccine targeting Foxp3
    Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
    Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.
    Bauer C; Sterzik A; Bauernfeind F; Duewell P; Conrad C; Kiefl R; Endres S; Eigler A; Schnurr M; Dauer M
    Cancer Immunol Immunother; 2014 Apr; 63(4):321-33. PubMed ID: 24384835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice.
    Selvanesan BC; Meena K; Beck A; Meheus L; Lara O; Rooman I; Gravekamp C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33154149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer.
    Zheng Y; Dou Y; Duan L; Cong C; Gao A; Lai Q; Sun Y
    Cell Immunol; 2015 Mar; 294(1):54-9. PubMed ID: 25687508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.
    Cornelissen R; Hegmans JP; Maat AP; Kaijen-Lambers ME; Bezemer K; Hendriks RW; Hoogsteden HC; Aerts JG
    Am J Respir Crit Care Med; 2016 May; 193(9):1023-31. PubMed ID: 26652184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
    Kawano M; Itonaga I; Iwasaki T; Tsumura H
    Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity.
    Sheybani ND; Witter AR; Thim EA; Yagita H; Bullock TNJ; Price RJ
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32819975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [
    Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM
    Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
    Bazargan S; Bunch B; Ojwang' AME; Blauvelt J; Landin A; Ali J; Abrahams D; Cox C; Hall AM; Beatty MS; Poch M; Rejniak KA; Pilon-Thomas S
    Front Immunol; 2023; 14():1275375. PubMed ID: 37901214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.